When Nothing Turns Itself Inside out and Becomes Something: Coating Poly(Lactic-Co-Glycolic Acid) Spheres with Hydroxyapatite Nanoparticles vs. the Other Way Around
Source abstract
Abstract
To stabilize drugs physisorbed on the surface of hydroxyapatite (HAp) nanoparticles and prevent burst release, these nanoparticles are commonly coated with polymers. Bioactive HAp, however, becomes shielded from the surface of such core/shell entities, which partially defeats the purpose of using it. The goal of this study was to assess the biological and pharmacokinetic effects of inverting this classical core/shell structure by coating poly(lactic-co-glycolic acid) (PLGA) spheres with HAp nanoparticles. The HAp shell did not hinder the release of vancomycin; rather, it increased the release rate to a minor degree, compared to that from undecorated PLGA spheres. The decoration of PLGA spheres with HAp induced lesser mineral deposition and lesser upregulation of osteogenic markers compared to those induced by the composite particles where HAp nanoparticles were embedded inside the PLGA spheres. This was explained by homeostatic mechanisms governing the cell metabolism, which ensure than the sensation of a product of this metabolism in the cell interior or exterior is met with the reduction in the metabolic activity. The antagonistic relationship between proliferation and bone production was demonstrated by the higher proliferation rate of cells challenged with HAp-coated PLGA spheres than of those treated with PLGA-coated HAp. It is concluded that the overwhelmingly positive response of tissues to HAp-coated biomaterials for bone replacement is unlikely to be due to the direct induction of new bone growth in osteoblasts adhering to the HAp coating. Rather, these positive effects are consequential to more elementary aspects of cell attachment, mechanotransduction, and growth at the site of contact between the HAp-coated material and the tissue.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
TardigradeNano LLC., 7 Park Vista, Irvine, CA 92604, USA
Department of Mechanical Engineering, San Diego State University, 5500 Campanile Dr., San Diego, CA 92182, USA
Funding
National Institute of Dental and Craniofacial Research
References (69)
Show source-provided references
1. When 1 + 1 > 2: Nanostructured Composite Materials for Hard Tissue Engineering Applications10.1016/j.msec.2015.07.050 ↗
2. Nanotechnologies: What We Do Not Know10.1016/j.techsoc.2006.10.005 ↗
3. Waiting for Aπαταω: 250 Years Later10.1007/s10699-019-09602-x ↗
4. Release of Salivary Proteins from Hydroxyapatite and Enamel by Elution by Phosphate Buffer
5. Chlorhexidine Uptake and Release by Hydroxyapatite and Human Salivary Sediment
6. Ion-Doped Hydroxyapatite: An Impasse or the Road to Follow?10.1016/j.ceramint.2020.02.001 ↗
7. Nanosized Hydroxyapatite and Other Calcium Phosphates: Chemistry of Formation and Application as Drug and Gene Delivery Agents
8. Chromatography of Nucleic Acids on Hydroxyapatite. I. Chromatography of Native DNA10.1016/0005-2787(69)90273-1 ↗
9. A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA10.1016/0042-6822(73)90341-3 ↗
10. Reible, D.D. (2014). Capping for Remediation of Contaminated Sediments. Processes, Assessment and Remediation of Contaminated Sediments, Springer.10.1007/978-1-4614-6726-7 ↗
11. Gene Delivery Using Calcium Phosphate Nanoparticles: Optimization of the Transfection Process and the Effects of Citrate and Poly(L-Lysine) as Additives10.1016/j.jcis.2016.03.007 ↗
12. Hydroxyapatite as a Biomaterial—A Gift that Keeps on Giving10.1080/03639045.2020.1776321 ↗
13. Calcium Phosphate Nanoparticles as Intrinsic Inorganic Antimicrobials: In Search of the Key Particle Property10.1116/1.5090396 ↗
14. Drug Release and Bone Growth Studies of Antimicrobial Peptide-Loaded Calcium Phosphate Coating on Titanium
15. Phase Composition Control of Calcium Phosphate Nanoparticles for Tunable Drug Delivery Kinetics and Treatment of Osteomyelitis. I. Preparation and Drug Release
16. Unexpectedly High Adsorption Capacity of Esterified Hy-droxyapatite for Heavy Metal Removal10.1021/acs.langmuir.9b02373 ↗
17. Synthesis of Antibiotic-Loaded Interporous Hydroxyapatite Blocks by Vacuum Method and in vitro Drug Release Testing10.1016/S0142-9612(97)00237-8 ↗
18. Poly(d,l-Lactide-co-Glycolide)/Hydroxyapatite Core–Shell Nanospheres. Part 3: Properties of Hydroxyapatite Nano-rods and In-vestigation of a Distribution of the Drug within the Composite10.1016/j.colsurfb.2011.05.023 ↗
19. Effects of Hydroxyapatite@Poly-Lactide-Co-Glycolide Nanoparticles Combined with Pb and Cd on Liver and Kidney Parenchyma after the Reconstruction of Mandibular Bone Defects10.1039/C9TX00007K ↗
20. Selective Anticancer Activity of Lung-Targeting Hydroxyapatite/Chitosan-Poly(D,L)-Lactide-co-Glycolide Particles Loaded with an Androstane-Based Cancer Inhibitor10.1016/j.colsurfb.2016.09.041 ↗
21. Gold as a Dopant in Selenium-Containing Carbonated Hydroxyapatite Fillers of Nanofibrous ε-Polycaprolactone Scaffolds for Tissue Engineering10.1016/j.ijpharm.2019.118950 ↗
22. Tuning the Mechanical, Microstructural and Cell Adhesion Properties of Electrospun ε-Polycaprolactone Microfibers by Doping Selenium-Containing Carbonated Hydroxyapatite as the Reinforcing Agent with Magnesium Ions10.1007/s10853-019-03947-1 ↗
23. Poly(Lactide-co-Glycolide)/Hydroxyapatite Composite Scaffolds for Bone Tissue Engineering10.1016/j.biomaterials.2005.08.016 ↗
24. Preparation of Polymer Particles Coated with Hydroxyapatite10.1006/jcis.1998.6023 ↗
25. Apatite-Coated Poly(Lactic-co-Glycolic Acid) Microspheres as an Injectable Scaffold for Bone Tissue Engineering10.1002/jbm.a.31572 ↗
26. Controlled Release of Amoxicillin From Hydroxyapatite-Coated Poly(lactic-Co-Glycolic Acid) Micro-spheres10.1016/j.jconrel.2008.01.017 ↗
27. Growth of Hydroxyapatite Coatings on Biodegradable Polymer Micro-spheres10.1021/am9001716 ↗
28. Microwave-Induced Rapid Formation of Biomimetic Hydroxy-apatite Coating on Gelatin-Siloxane Hybrid Microspheres in 10X-SBF Solution10.1515/epoly-2017-0196 ↗
29. Growth of Hydroxyapatite Coating on Polymer Microspheres10.1166/nnl.2011.1204 ↗
30. Poly(D,L-Lactide-Co-Glycolide)/Hydroxyapatite Core-Shell Nanospheres. Part 1: A Multifunctional System for Controlled Drug Delivery10.1016/j.colsurfb.2010.09.011 ↗
31. In vitro Analysis of Nanoparticulate Hydroxyapatite/Chitosan Composites as Potential Drug Delivery Platforms for the Sustained Release of Antibiotics in the Treatment of Osteomyelitis10.1002/jps.23824 ↗
32. Wojcik-Pastuszka, D., Krzak, J., Macikowski, B., Berkowski, R., Osiński, B., and Musiał, W. (2019). Evaluation of the Release Kinetics of a Pharmacologically Active Substance from Model Intra-Articular Implants Replacing the Cruciate Ligaments of the Knee. Materials, 12.10.3390/ma12081202 ↗
33. Distinct Proliferative and Differentiated Stages of Murine MC3T3-E1 Cells in Culture: An in vitro Model of Osteoblast Development10.1002/jbmr.5650070613 ↗
34. Factors Defining the Stability of Poly(Lactide-co-Glycolide) Spheres for the Sustained Release of a Cysteine Protease Inhibitor10.1016/j.ijpharm.2020.119316 ↗
35. Di Natale, C., Onesto, V., Lagreca, E., Vecchione, R., and Netti, P.A. (2020). Tunable Release of Curcumin with an In Silico-Supported Ap-proach from Mixtures of Highly Porous PLGA Microparticles. Materials, 13.10.3390/ma13081807 ↗
36. A Comparative Study of the Effect of Drug Hydrophobicity on Nanoparticle Drug Delivery in vivo using Two Photosensitizers10.1016/j.nano.2020.102151 ↗
37. The Effect of Platelet-Rich Fibrin Exudate Addition to Porous Poly(Lactic-co-Glycolic Acid) Scaffold in Bone Healing: An in vivo Study10.1002/jbm.b.34478 ↗
38. Fibrous Bone Tissue Engineering Scaffolds Prepared by Wet Spinning of PLGA10.3906/biy-1904-63 ↗
39. Restoration of Osteochondral Defects by Implanting Bilayered Poly(Lactide-co-Glycolide) Porous Scaffolds in Rabbit Joints for 12 and 24 Weeks10.1016/j.jot.2019.04.006 ↗
40. PLGA-Based Nanoparticles as Cancer Drug Delivery Systems10.7314/APJCP.2014.15.2.517 ↗
41. Nanoparticulate Drug Delivery Platforms for Advancing Bone Infection Therapies10.1517/17425247.2014.944860 ↗
42. Activity of Fusidic Acid Against Extracellular and Intracellular Staphylococcus aureus: Influence of pH and Comparison With Linezolid and Clindamycin10.1093/cid/cir165 ↗
43. The Effects of Temperature and pH on the Growth of Eight Enteric and Nine Glucose Non-Fermenting Species of Gram-Negative Rods10.1111/j.1348-0421.1982.tb00149.x ↗
44. Hydroxyapatite Nanoparticles as Particulate Emulsifier: Fabrication of Hydroxyapatite-Coated Biodegradable Microspheres10.1021/la901100z ↗
45. Osteogenic and Antimicrobial Nanoparticulate Calcium Phosphate and/or Poly-Lactide-Co-Glycolide Powders for the Treatment of Osteomyelitis10.1016/j.msec.2013.04.023 ↗
46. Dynamic Light Scattering and Zeta Potential of Colloidal Mixtures of Amelogenin and Hydroxyapatite in Calcium and Phosphate Rich Ionic Milieus10.1016/j.archoralbio.2010.11.011 ↗
47. Calcium Phosphate Nanoparticles as Intrinsic Inorganic Antimicrobials: The Antibacterial Effect10.1021/acsami.8b12784 ↗
48. PLGA Microspheres for the Ocular Delivery of a Peptide Drug, Vancomycin using Emulsification/Spray-Drying as the Preparation Method: In vitro/in vivo Studies10.1016/j.ejpb.2003.10.018 ↗
49. pH-Responsive and Porous Vancomycin-Loaded PLGA Microspheres: Evidence of Controlled and Sustained Release for Localized Inflammation Inhibition in vitro10.1039/C8RA06659K ↗
50. Tseng, Y.Y., Kao, C.W., Liu, K.S., Tang, Y.L., Liu, Y.W., and Liu, S.J. (2020). Treating Intracranial Abscesses in Rats with Stereotactic Injection of Biodegradable Vancomycin-Embedded Microparticles. Pharmaceutics, 12.10.3390/pharmaceutics12020091 ↗
51. Revisiting the Fundamentals in the Design and Control of Nanoparticulate Colloids in the Frame of Soft Chemistry10.1134/S2079978013040031 ↗
52. Preparation of Spherical Macroporous Poly(Lactic-co-Glycolic Acid) for Bone Tissue Regeneration10.1049/iet-nbt.2013.0066 ↗
53. Caboxymetylcellulose/Gelatin Blends Loaded with Piroxicam: Preparation, Characterization and Evaluation of in Vitro Release Profile
54. Effect of Sodium Ascorbyl Phosphate on Osteoblast Viability and Differentiation10.1111/jre.12752 ↗
55. Phase Composition Control of Calcium Phosphate Nanoparticles for Tunable Drug Delivery Kinetics and Treatment of Osteomyelitis. II. Antibacterial and Osteoblastic Response
56. Bone Mineral Crystallinity Governs the Orchestration of Ossification and Resorption during Bone Remodeling10.1021/acsbiomaterials.9b00255 ↗
57. On the Relational Character of Mind and Nature
58. von Foerster, H. (1981). Observing Systems, Intersystems Publications.
59. Bateson, G. (1972). Steps to an Ecology of Mind, University of Chicago Press.
60. Does Translational Symmetry Matter on the Micro Scale? Fibroblastic and Osteoblastic Interactions with the Topographically Distinct Poly(ε-Caprolactone)/Hydroxyapatite Thin Films10.1021/am503043t ↗
61. Enhancing the Bioactivity of Poly(Lactic-co-Glycolic Acid) Scaffold with a Nano-Hydroxyapatite Coating for the Treatment of Segmental Bone Defect in a Rabbit Model10.2147/IJN.S43706 ↗
62. Rapid Mineralization of Hierarchical Poly(l-Lactic Acid)/Poly(ε-Caprolactone) Nanofibrous Scaffolds by Electrodeposition for Bone Regeneration10.2147/IJN.S205194 ↗
63. Cold-Spray Coating of Hydroxyapatite on a Three-Dimensional Polyetheretherketone Implant and its Biocompatibility Evaluated by in vitro and in vivo Minipig Model10.1002/jbm.b.33589 ↗
64. Polyether Ether Ketone Implants Achieve Increased Bone Fusion when Coated with Nano-Sized Hydroxyapatite: A Histomorphometric Study in Rabbit Bone10.2147/IJN.S100424 ↗
65. Interfacial and Biological Properties of the Gradient Coating on Polyamide Substrate for Bone Substitute10.1098/rsif.2014.0101 ↗
66. Surface Modification of Corneal Prosthesis with Nano-Hydroxyapatite to Enhance in vivo Biointegration10.1016/j.actbio.2020.01.023 ↗
67. Hydroxyapatite for Keratoprosthesis Biointegration10.1167/iovs.11-7601 ↗
68. Subcutaneous Tissue Response to Titanium, Poly(ε-Caprolactone), and Carbonate-Substituted Hydroxyapatite-Coated Poly(ε-Caprolactone) Plates: A Rabbit Study10.1002/jbm.a.34542 ↗
69. Bone Anchored Hearing Implant Surgery: 1 Year Follow-Up Data Shows No Effect of Hydroxyapatite Coating on Soft Tissue Reaction After Loading at 1 Week10.1097/MAO.0000000000001442 ↗